Shares of Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) were up 2.7% during trading on Thursday . The company traded as high as $7.46 and last traded at $7.34. Approximately 222,880 shares changed hands during trading, a decline of 60% from the average daily volume of 551,962 shares. The stock had previously closed at $7.15.
Cybin Trading Up 3.7 %
The stock has a market cap of $1.12 billion and a price-to-earnings ratio of -31.54. The firm’s 50-day moving average is $9.03 and its two-hundred day moving average is $8.47.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Further Reading
- Five stocks we like better than Cybin
- Insider Trades May Not Tell You What You Think
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Stock Analyst Ratings and Canadian Analyst Ratings
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Does a Stock Split Mean?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
